For the year ending 2025-12-31, CPMD has $7,018,404 in assets. $37,172,133 in debts.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 1,804 | |||
| Goods and services tax receivable | 29,832 | |||
| Accounts receivable | 164,430 | |||
| Inventory | 1,115,322 | |||
| Total current assets | 1,311,388 | |||
| Equipment, net | 127,029 | |||
| Right-of-use building, net | 5,579,987 | |||
| Investments | 0 | |||
| Total assets | 7,018,404 | |||
| Accounts payable and accrued liabilities | 10,059,415 | |||
| Accrued interest | 1,720,278 | |||
| Deferred revenue | 260,561 | |||
| Notes payable | 482,661 | |||
| Convertible notes | 1,017,004 | |||
| Derivative conversion feature | 2,009,476 | |||
| Loans payable to related parties, current portion | 12,567,911 | |||
| Royalty payable | 305,492 | |||
| Liability for right-of-use building, current portion | 1,000,479 | |||
| Obligation to issue shares | 2,166,681 | |||
| Total current liabilities | 31,589,958 | |||
| Loans payable to related parties | 548,574 | |||
| Liability for right-of-use building | 5,033,601 | |||
| Total liabilities | 37,172,133 | |||
| Preferred stock, value-Series APreferred Stock | 74,416 | |||
| Preferred stock, value-Series BPreferred Stocks | 455,000 | |||
| Preferred stock, value-Series CPreferred Stock | 100,000 | |||
| Common shares, 0.0001 par value 5,000,000,000 shares authorized, 662,501,405 issued and outstanding as at december 31, 2025 and 2024 | 66,250 | |||
| Shares to be issued | 1,600 | |||
| Treasury shares | 623 | |||
| Additional paid-in capital | 81,520,643 | |||
| Accumulated deficit | -112,315,590 | |||
| Accumulated other comprehensive (loss) income | -56,671 | |||
| Total shareholders' deficit | -30,153,729 | |||
| Total liabilities and shareholders' deficit | 7,018,404 | |||
CANNAPHARMARX, INC. (CPMD)
CANNAPHARMARX, INC. (CPMD)